Avanos Medical, Inc.

NYSE:AVNS 株式レポート

時価総額:US$802.8m

Avanos Medical 将来の成長

Future 基準チェック /06

Avanos Medicalは収益が増加すると予測されています。

主要情報

n/a

収益成長率

n/a

EPS成長率

Medical Equipment 収益成長17.1%
収益成長率4.6%
将来の株主資本利益率n/a
アナリストカバレッジ

Low

最終更新日31 Oct 2024

今後の成長に関する最新情報

Recent updates

Avanos Medical, Inc.'s (NYSE:AVNS) Price Is Right But Growth Is Lacking

Oct 25
Avanos Medical, Inc.'s (NYSE:AVNS) Price Is Right But Growth Is Lacking

There May Be Some Bright Spots In Avanos Medical's (NYSE:AVNS) Earnings

Aug 07
There May Be Some Bright Spots In Avanos Medical's (NYSE:AVNS) Earnings

Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S

Apr 17
Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S

Is Avanos Medical (NYSE:AVNS) A Risky Investment?

Jan 05
Is Avanos Medical (NYSE:AVNS) A Risky Investment?

Some Avanos Medical, Inc. (NYSE:AVNS) Analysts Just Made A Major Cut To Next Year's Estimates

Aug 14
Some Avanos Medical, Inc. (NYSE:AVNS) Analysts Just Made A Major Cut To Next Year's Estimates

When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?

Aug 13
When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?

Avanos Medical: Leaning Up, Attractive Returns On Incremental Capital, Reiterate Buy

Jul 16

We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease

Jun 05
We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease

Avanos Medical, Inc. (NYSE:AVNS) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

May 18
Avanos Medical, Inc. (NYSE:AVNS) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

Avanos Medical (NYSE:AVNS) Is Looking To Continue Growing Its Returns On Capital

May 07
Avanos Medical (NYSE:AVNS) Is Looking To Continue Growing Its Returns On Capital

Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?

Mar 02
Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?

Avanos Medical Q4 2022 Earnings Preview

Feb 20

Avanos Medical, Inc. (NYSE:AVNS) Shares Could Be 30% Below Their Intrinsic Value Estimate

Feb 10
Avanos Medical, Inc. (NYSE:AVNS) Shares Could Be 30% Below Their Intrinsic Value Estimate

Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching

Jan 13
Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching

Avanos Medical reports Q3 mixed earnings; reaffirms FY22 guidance

Nov 02

Avanos: Recent Entry To Hyaluronic Acid Market Sparks Interesting Debate

Sep 12

Avanos Medical Q2 2022 Earnings Preview

Aug 08

When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?

May 28
When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?

Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?

May 03
Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?

Is There An Opportunity With Avanos Medical, Inc.'s (NYSE:AVNS) 41% Undervaluation?

Feb 10
Is There An Opportunity With Avanos Medical, Inc.'s (NYSE:AVNS) 41% Undervaluation?

Should You Think About Buying Avanos Medical, Inc. (NYSE:AVNS) Now?

Dec 21
Should You Think About Buying Avanos Medical, Inc. (NYSE:AVNS) Now?

An Intrinsic Calculation For Avanos Medical, Inc. (NYSE:AVNS) Suggests It's 33% Undervalued

Nov 04
An Intrinsic Calculation For Avanos Medical, Inc. (NYSE:AVNS) Suggests It's 33% Undervalued

業績と収益の成長予測

NYSE:AVNS - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/2026756N/AN/AN/A1
12/31/2025713N/AN/AN/A3
12/31/2024685N/AN/AN/A3
9/30/2024682223756N/A
6/30/202468274262N/A
3/31/2024680-21331N/A
12/31/2023673-101532N/A
9/30/2023682-113753N/A
6/30/202368393553N/A
3/31/2023684186482N/A
12/31/2022684227291N/A
9/30/20226962390109N/A
6/30/2022708-2386104N/A
3/31/2022723107292N/A
12/31/2021587-316687N/A
9/30/2021736-521536N/A
6/30/20217382-514N/A
3/31/2021715-38-21N/AN/A
12/31/2020715-29-23-2N/A
9/30/202072014-30-6N/A
6/30/2020705-17-51-24N/A
3/31/2020714-22-100-57N/A
12/31/2019698-46-125-74N/A
9/30/2019678-42-139-79N/A
6/30/2019671-27-194-130N/A
3/31/2019660-17-247-195N/A
12/31/2018652-8-195-146N/A
9/30/2018649-1-118-74N/A
6/30/2018634-16N/A17N/A
3/31/2018622-28N/A134N/A
12/31/2017612-32N/A144N/A
9/30/2017-171-150N/A125N/A
6/30/201776-130N/A152N/A
3/31/2017327-112N/A183N/A
12/31/2016566-83N/A189N/A
9/30/20161,58444N/A167N/A
6/30/20161,576-435N/A136N/A
3/31/20161,565-434N/A100N/A
12/31/2015509-101N/A98N/A
9/30/20151,612-443N/A115N/A
6/30/20151,63120N/A120N/A
3/31/20151,6567N/A162N/A
12/31/20141,67227N/A148N/A
9/30/20141,66469N/A184N/A
6/30/20141,675125N/A222N/A
3/31/20141,677168N/A210N/A
12/31/20131,678155N/A224N/A

アナリストによる今後の成長予測

収入対貯蓄率: AVNSの予測収益成長が 貯蓄率 ( 2.6% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: AVNSの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: AVNSの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: AVNSの収益 ( 4.6% ) US市場 ( 8.9% ) よりも低い成長が予測されています。

高い収益成長: AVNSの収益 ( 4.6% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: AVNSの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘